• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Oncology

AstraZeneca is pleased to present healthcare professionals with a variety of oncology resources for your informational purposes. The educational materials are intended to provide information that can assist you in forming your own clinical and treatment decisions.

  1. Congress Library
  2. Medications
  3. Disease Education
  4. Continuing Education
  5. Pipeline

January 25 - 27, 2024

ASCO GU 2024 

Explore AstraZeneca Scientific Materials Visit website

January 18 - 20, 2024

ASCO GI 2024 

Explore AstraZeneca Scientific Materials Visit website

December 09-12, 2023

American Society Of Hematology (ASH) 2023

Explore AstraZeneca Scientific Materials Visit website

December 06-08, 2023

ESMO IO 2023

Explore AstraZeneca Scientific Materials Visit website

December 05-09, 2023

San Antonio Breast Cancer Symposium (SABCS) 2023

Explore AstraZeneca Scientific Materials Visit website

December 01-03, 2023

ESMO Asia 2023

Explore AstraZeneca Scientific Materials Visit website

October 20-24, 2023

European Society For Medical Oncology (ESMO) 2023

Explore AstraZeneca Scientific Materials Visit website

September 9-12, 2023

World Conference On Lung Cancer (WCLC) 2023

Explore AstraZeneca Scientific Materials Visit website

June 8 - June 15, 2023

European Hematology Association (EHA) 2023

Explore AstraZeneca Scientific Materials Visit website

June 2 - June 6, 2023

American Society of Clinical Oncology (ASCO) 2023

Explore AstraZeneca Scientific Materials Visit website

May 11 - May 13, 2023

ESMO Breast 2023

Explore AstraZeneca Scientific Materials Visit website

April 28 - May 1, 2023

American Urological Association (AUA) - 2023 Annual Meeting

Explore AstraZeneca Scientific Materials Visit website

April 14 - 19, 2023

American Association for Cancer Research Annual Meeting 2023

Explore AstraZeneca Scientific Materials Visit website

February 23 - 24, 2023

European Society for Medical Oncology (ESMO GYN) 2023

Explore AstraZeneca Scientific Materials Visit website

February 16 - 18, 2023

American Society of Clinical Oncology: Genitourinary Cancers Symposium (ASCO-GU)

Explore AstraZeneca Scientific Materials Visit website

pipeline

This page provides access to AstraZeneca presentations and posters shared during the congresses listed below. Content availability is subject to the timeliness and permissions outlined by respective congresses.

EHA 2025

European Hematology Association

 

June 12-15, 2025

Visit website

 

 

ASCO 2025

American Society of Clinical Oncology

 

May 30 - June 03, 2025

Visit website

 

 

AUA 2025

American Urological Association's 2025 Annual Meeting

 

April 26 – 29, 2025

Visit website

 

 

AACR 2025

American Association for Cancer Research

 

April 25 - 30, 2025

Visit website

 

 

ELCC 2025

European Lung Cancer Congress

 

March 26 - 29, 2025

Visit website

 

 

EAU 2025

40th Annual European Association of Urology

 

March 21 - 24, 2025

Visit website

 

 

ASCO GU 2025

American Society of Clinical Oncology Genitourinary Cancers Symposium

 

February 13 - 15, 2025

Visit website

 

 

ASCO GI 2025

American Society of Clinical Oncology - Gastrointestinal Cancers 

 

January 23-25, 2025

Visit website

 

 

ESMO IO 2024

European Society for Medical Oncology - Immuno-Oncology

 

December 11 - 13, 2024

Visit website

 

 

SABCS 2024

San Antonio Breast Cancer Symposium

 

December 10 - 13, 2024

Visit website

 

 

ASH 2024

American Society of Hematology

 

December 7 - 10, 2024

Visit website

 

 

ESMO Asia

European Society for Medical Oncology Asia

 

December 06 - 08, 2024

Visit website

 

 

ESMO 2024

European Society for Medical Oncology

 

September 13 - 17, 2024

Visit website

 

 

WCLC 2024

World Conference on Lung Cancer

 

September 07 - 10, 2024

Visit website

 

 

ESMO GI 2024

European Society for Medical Oncology - Gastrointestinal Cancers

 

June 26 - 29, 2024

Visit website

 

 

ESMO GYN 2024

European Society for Medical Oncology - Gynaecological Cancers

 

June 20 - 22, 2024

Visit website

 

 

EHA 2024

European Hematology Association 

 

June 13 - 16, 2024

Visit website

 

 

ASCO 2024

American Society of Clinical Oncology

 

May 31 - June 4, 2024

Visit website

 

 

ESMO Breast 2024

European Society for Medical Oncology - Breast Cancer 

 

May 15 - 17, 2024

Visit website

 

 

  • CALQUENCE<sup>®</sup> (acalabrutinib) Tablets
  • ENHERTU<sup>®</sup> (fam-trastuzumab deruxtecan-nxki)
  • ENHERTU<sup>®</sup> (fam-trastuzumab deruxtecan-nxki)
  • FASLODEX<sup>®</sup> (fulvestrant) injection, for intramuscular use
  • IMFINZI<sup>®</sup> (durvalumab) injection, for intravenous use
  • IMJUDO (tremelimumab)
  • IRESSA<sup>®</sup> (gefitinib) Tablets
  • LYNPARZA<sup>®</sup> (olaparib) Tablets
  • TAGRISSO<sup>®</sup> (osimertinib) Tablets
  • TAGRISSO<sup>®</sup> Japanese
  • TAGRISSO<sup>®</sup> Korean
  • TAGRISSO<sup>®</sup> Spanish
  • TAGRISSO<sup>®</sup> Mandarin
  • TAGRISSO<sup>®</sup> Tagalog
  • TAGRISSO<sup>®</sup> Vietnamese
  • TRUQAP (capivasertib)

WEBSITE

HER2Know

HER2 IHC Testing in Solid Tumors


Email Recipient

  1. Colleague
  2. Myself

VIDEO

VIDEO

HER2 NSCLC Mutation MOD Animation

This video is a series of 3D animated videos on HER2 mutations in NSCLC.


WEBSITE

e-Learning

Web Critical Clues: Identifying and Managing Interstitial Lung Disease in Patients With Breast Cancer

PRIME Education, LLC

17-Feb-2025 to 16-Feb-2026

1-hour Multi-Accredited, On-Demand Enduring Webcast with Downloadable POC Resource

Learn More

e-Learning

Emerging Clinical Data for Targeting HER2 in Bladder Cancer

PRIME Education, LLC

20-May-2025 to 20-May-2025

One (1) 0.5-hour Multi-Accredited, Live Clinical Connections National Webinar 3-Part Series (3 of 3)

Learn More

e-Learning

Stepping Forward to Transform Mantle Cell Lymphoma (MCL) Management: Guidance on the Selection and Use of Bruton Tyrosine Kinase Inhibitor (BTKi) Platforms as First-Line Therapy

PVI, PeerView Institute for Medical Education

19-June-2024 to 18-July-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Nurse-Led Strategies for Optimizing PARP Inhibitor Therapies in Veterans With Prostate Cancer: Insights for Practical Care Delivery

PVI, PeerView Institute for Medical Education

30-Oct-2024 to 29-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Surgical Approach to HCC

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on surgical approaches, downstaging and bridging and community practice.

Learn More

e-Learning

Transplant approach from the transplant surgeon and hepatologist

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on pre/peri/post transplant.

Learn More

e-Learning

Ablative modalities: tried and true, and up and coming for HCC

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on frequently used modality, descriptions on how each ablative modality works, the transition to histotripsy. 

Learn More

e-Learning

How to dose: understanding Y-90 dosimetry from simple to complex

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on what makes sense, where are we headed and how to simplify things regarding dosimetry.

Learn More

e-Learning

How to build an IO practice

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on PP vs Academics, what does your support staff look like, finding referrals, greatest successes and failures in year 1.

Learn More

e-Learning

Advanced HCC: Combination therapy and Clinical trials: what they really mean

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on Immunotherapy in HCC, what are the impactful immunotherapy trials in HCC, and immunotherapy medications.

Learn More

e-Learning

The “grey” zone, BCLC B and complex patients

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions and review on BCLC guidelines, role of ablation, TACE, TARE and systemic therapies, Grey Zone/complex patients scenarios and post-treatment patients.

Learn More

e-Learning

Tumor Board Collaboration: Disease Progression

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Case-based discussions with a multidisciplinary approach/team to treating HCC. 

Learn More

e-Learning

Patient flow - too many cooks in the kitchen?

BackTable, LLC

17-Jan-2025 to 31-Dec-2025

Discussions on the benefits of multidisciplinary clinic and navigating the patient experience

Learn More

e-Learning

2024-2025 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

National Comprehensive Cancer Network, Inc.

19-Aug-2024 to 31-May-2025

NCCN will offer a series of nine (9) live multidisciplinary case-based webinars on the care of patients with various cancer types

Learn More

e-Learning

2024-2025 Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient

National Comprehensive Cancer Network, Inc.

30-Aug-2024 to 29-Jun-2026

In order to extend the reach of this program, NCCN will archive the webinars from this activity on NCCN’s Learning Management System found at http://education.nccn.org.  The archived recordings will consist of slides and audio.  

Learn More

e-Learning

Behind the Guidelines: Insights into the Standard of Care in Oncology 2025

National Comprehensive Cancer Network, Inc.

10-Jan-2025 to 31-Dec-2026

This activity consists of twelve NCCN Guidelines Insights articles 

Learn More

e-Learning

Live NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology

National Comprehensive Cancer Network, Inc.

01-Feb-2025 to 31-Dec-2025

This activity is a series of 9 webinars on a variety of oncopharmacology topics that will be presented from February 2025 - December 2025. 

Learn More

e-Learning

Web NCCN 2025 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology

National Comprehensive Cancer Network, Inc.

01-Feb-2025 to 30-Dec-2026

This activity is a series of 9 webinars on a variety of oncopharmacology topics that will be presented from February 2025 - December 2025. 

Learn More

e-Learning

Web enduring NCCN 2025 Breast Cancer Congress with Updates from the 2024 San Antonio Breast Cancer Symposium

National Comprehensive Cancer Network, Inc.

15-Mar-2025 to 14-Mar-2026

National Comprehensive Cancer Network (NCCN) plans to conduct a one-day live-in-person educational activity.NCCN will offer the eight (8) sessions from this activity as archived endured webcasts 

Learn More

e-Learning

Behind the Guidelines: Insights into the Standard of Care in Oncology 2024

National Comprehensive Cancer Network, Inc.

10-Jan-2024 to 31-Dec-2025

This activity consists of twelve NCCN Guidelines Insights articles.  10 in print, 2 electronically 

Learn More

e-Learning

We Can Make a Difference: Metastatic Breast Cancer Updates

Texas Pharmacy Association

07-Feb-2025 to 06-Feb-2027

1-hour recorded Zoom webinar, with expert oncology pharmacist

Learn More

e-Learning

Web enduring Essential Updates and Expert Perspectives in Gynecologic Malignancies: Independent 2024 Conference/Congress Coverage *

Clinical Care Options, LLC

25-Jul-2024 to 24-May-2025

Online Activities:

• A downloadable “living” slideset

• 3 CME-Certified ClinicalThought expert commentaries

• 2 podcasts hosted on the CCO Oncology podcast channel and other streaming platforms

Learn More

e-Learning

Application of Evolving Evidence in Mantle Cell Lymphoma: Therapeutic Strategies Using BTK Inhibitors

Clinical Care Options, LLC   

13-Dec-2024 to 30-Jun-2025

Enduring Online Activities

• CME/ABIM MOC-Certified Webcast

• Downloadable Self-Study and Teaching Slideset Resource

• ClinicalThought commentary: “Experts Answer Your Questions” on MCL

Learn More

e-Learning

Estrogen Receptor Mutations in HR+ Advanced Breast Cancer: Next-Generation Practice Recommendations on Mutation Screening to Guide Therapeutic Decisions

Clinical Care Options, LLC   

13-Nov-2024 to 30-Dec-2025

Online Activities:

•      An on-demand CME/ABIM MOC–certified webcast

•       Downloadable PowerPoint slidesets on the CCO website

•       Podcast featuring panel discussion from the live symposium

Learn More

e-Learning

Web enduring New Antibody–Drug Conjugates for NSCLC in the Limelight: Expert Guidance on the Integration of TROP-2–Targeting Agents Into Clinical Practice

Clinical Care Options, LLC

29-Feb-2024 to 29-Aug-2025

CME-certified initiative informed by a “Collaborative Learning Experience Study” designed to educate healthcare professionals on the clinical integration of TROP-2–targeted antibody–drug conjugates (ADCs) in non-small-cell lung cancer treatment.

Learn More

e-Learning

Web 2023-2024 Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care

National Comprehensive Cancer Network, Inc.

30-Jun-2023 to 29-Jun-2025

Web Enduring -  a series of twelve (12) live multidisciplinary case-based webinars 

Learn More

e-Learning

(NAVREF 2024 Annual Conference) Prostate Cancer Care in the Veterans Administration (VA) Health System: Adapting and Integrating Evolving Innovation in the Treatment of De Novo mHSPC

HMP Education, LLC

16-Oct-2024 to 16-Oct-2025

To extend the reach to learners who are unable to attend the 2024 NAVREF Satellite Symposium, HMP Education will capture and archive the recorded session proceedings for a chapterized on-demand CME/CE-certified web viewing. 

Learn More

e-Learning

Improving Outcomes for Advanced/Unresectable Hepatocellular Carcinoma: Immune Checkpoint Inhibitor-Based Strategies in First-Line Therapy

HMP Education, LLC

19-Nov-2024 to 19-Nov-2025

Enduring web archive of the live session 

Learn More

e-Learning

Targeting HER2 Overexpression in Gastroesophageal and Colorectal Cancers: Novel and Emerging Options

HMP Education, LLC

19-Nov-2024 to 19-Nov-2025

To extend program reach to learners unable to participate in the live events, HMP Education developed an enduring on-demand archive of the live curriculum

Learn More

e-Learning

Hot Topics in Bladder and Prostate Cancer: Latest Treatments and Case-Based Learnings

HMP Education, LLC

06-Jan-2025 to 06-Jan-2026

HMP Education produced a CME/CE-certified enduring on-demand archive based on the live session proceedings

Learn More

e-Learning

Optimizing Therapy for Patients with Chronic Lymphocytic Leukemia: First Line Decision-Making and Beyond

HMP Education, LLC

20-Nov-2024 to 19-Nov-2025

To extend program reach to learners unable to participate in the live events, HMP Education developed an enduring on-demand archive of the live curriculum.

Learn More

e-Learning

CLL Landscape: Research and Clinical Advances

HMP Education, LLC

10-Mar-2025 to 10-Mar-2026

This initiative was designed to address the latest advancements and practical insights in CLL through dynamic discussions with leading experts and peers.

Learn More

e-Learning

Lymphoma Landscape: Research and Clinical Advances

HMP Education, LLC

10-Mar-2025 to 10-Mar-2026

This initiative was designed to address the latest advancements and practical insights in lymphoma, drawn from recent global research and developments through dynamic discussions with leading experts and peers.

Learn More

e-Learning

Targeted Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

HMP Education, LLC

29-Aug-2024 to 29-Aug-2025

Enduring on-demand web archive of the session held at the 2024 GDU in Hematologic Malignancies event series.

Learn More

e-Learning

Web HR+/HER2- Metastatic Breast Cancer: Addressing Unmet Needs and Endocrine Therapy Resistance in Frontline Treatment

HMP Education, LLC

02-Dec-2024 to 02-Dec-2025

Chapterized Enduring On-Demand Archive of the live session

Learn More

e-Learning

(2024 GDU Lung) Targeting HER2-Mutant NSCLC: A Focus on Biomarker Testing and Targeted Therapies

HMP Education, LLC

05-Nov-2024 to 05-Nov-2025

To extend program reach to individuals unable to participate in the live events, HMP Education will develop an enduring on-demand live session archive.

Learn More

e-Learning

Web Enduring Best of SABCS On-Demand

The University of Texas Health Science Center at San Antonio

01-Mar-2025 to 01-Nov-2025

The on demand format offers d peer-to-peer discussion. The programs also include clinical case scenarios for interactivity with the audience, providing a valuable educational resource for the practicing clinician

Learn More

e-Learning

National Lymphoma Round meeting #20

Purdue University

28-May-2025 to 28-May-2025

Live Virtual, 1.5-hours Meeting #20

Learn More

e-Learning

Optimizing the Use of BTK Inhibitors in the Treatment of Chronic Lymphocytic Leukemia (CLL): Informed Managed Care Decision Making in an Evolving Landscape

National Association of Managed Care Physicians, Inc.

01-Nov-2023 to 01-Nov-2025

CLL Enduring Webcasts

Learn More

e-Learning

Informed Managed Care Decision-Making in the Management of Chronic Lymphocytic Leukemia (CLL): Optimizing Clinical and Economic Outcomes with BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Aug-2024 to 01-Aug-2025

Enduring Webcast

Learn More

e-Learning

Web Best Practices in the Treatment and Management of HER2-Positive Advanced Breast Cancer: Expert Managed Care Strategies for Improved Clinical and Economic Outcomes

National Association of Managed Care Physicians, Inc.

01-Aug-2024 to 01-Aug-2025

Enduring Webcast

Learn More

e-Learning

Innovative Approaches in the Treatment and Management of Mantle Cell Lymphoma (MCL): A Closer Look at the Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Oct-2024 to 01-Oct-2026

Enduring Webcast

Learn More

e-Learning

Web enduring Evolving Considerations in the Treatment and Management of HER2-Negative Early Breast Cancer: Optimizing Targeted Therapy for Improved Patient Outcomes

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

Enduring Webcast

Learn More

e-Learning

Web enduring Best Practices in the Treatment and Management of Ovarian Cancer: Expert Managed Care Strategies on the Evolving Role of PARP Inhibitors

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

Enduring Webcast

Learn More

e-Learning

Evolving Considerations in the Treatment and Management of Chronic Lymphocytic Leukemia (CLL): Managed Care Insights on Evolving Role of BTK Inhibitors

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

Enduring Webcast

Learn More

e-Learning

Web enduring Innovative Approaches in the Treatment and Management of HER2-Positive and HER2-Low Breast Cancer: Managed Care Insights in an Evolving Paradigm

National Association of Managed Care Physicians, Inc.

01-Mar-2025 to 01-Mar-2026

Enduring Webcast

Learn More

e-Learning

Web enduring The Human Side of Breast Cancer: Using Novel Data and Patient Voices to Optimize Patient-Centered Care in HER2-Positive Breast Cancer Brain Metastases

Efficient LLC

23-Jul-2025 to 23-Jul-2026

60-minute multimedia activity enduring expert roundtable

Learn More

e-Learning

An Evolving Standard of Care in Chronic Lymphocytic Leukemia: Patient Perspectives and Clinical Insights on Novel Therapeutic Strategies Across the Disease Continuum

Efficient LLC

23-Jul-2025 to 23-Jul-2026

60-minute multimedia activity expert roundtable

Learn More

e-Learning

APPlexus GI: Clinic-Ready Insights from the Top Abstracts Presented at the 2024 Gastrointestinal Cancers Symposium

Clinical Care Options, LLC   

08-Mar-2024 to 20-June-2025

A live, immersive virtual educational event explicitly tailored for advanced practice providers. Activities include: Certified enduring webcast and downloadable slideset

Learn More

e-Learning

Novel and Emerging Evidence in Early-Stage Breast Cancer

PRIME Education, LLC

12-Jul-2024 to 11-Jul-2025

(One) 1.0-hour Enduring Webcast #1

Learn More

e-Learning

The Emergence of a New Subtype: HER2-Low Breast Cancer

PRIME Education, LLC

02-Aug-2024 to 01-Aug-2025

(One) 0.5-hour Enduring Webcast #2

Learn More

e-Learning

Antibody-Drug Conjugates in Breast Cancer

PRIME Education, LLC

23-Aug-2024 to 22-Aug-2025

(One) 1.0-hour Enduring Webcast #3 w/ whiteboard animation video

Learn More

e-Learning

Web Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations

PRIME Education, LLC

13-Nov-2024 to 12-Nov-2025

1.0-hour Clinical Connections Webcast

Learn More

e-Learning

Web Improving Outcomes for Patients With HR+/HER2- Advanced Breast Cancer

PRIME Education, LLC

22-May-2025 to 21-May-2026

1.0-hour Enduring Webcast with Downloadable HR+/HER2- Advanced Breast Cancer Pocket Guide

Learn More

e-Learning

Web Meeting the Moment: Improving Care for Patients With HER2-Low Breast Cancer

PRIME Education, LLC

09-May-2025 to 08-May-2026

One (1) 1.0-hour Multi-Accredited On-Demand Video

Learn More

e-Learning

Novel and Emerging Treatment Strategies in Triple-Negative Breast Cancer: Antibody-Drug Conjugates, Immunotherapy, and Targeted Therapies

PRIME Education, LLC

17-Jun-2025 to 18-Jun-2026

Webinar #2 (1.5-hours) Novel and Emerging Treatment Strategies in Triple Negative Breast Cancer: Antibody-Drug Conjugates, Immunotherapy, and Targeted Therapies – featuring a Clinician Spotlight

Learn More

e-Learning

Navigating Endocrine Resistance in HR+/HER2- Breast Cancer: Novel SERDS, SERMS, and Targeted Therapies

PRIME Education, LLC

09-Jul-2025 to 10-Jul-2026

Webinar #3 (1.5-hours) Navigating Endocrine Resistance in HR+/HER2- Breast Cancer: Novel SERDS, SERMS, and Targeted Therapies

Learn More

e-Learning

Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

PRIME Education, LLC

31-Jul-2025 to 01-Aug-2026

Webinar #4 (1.0-hour) Not as Easy as ADC: Selecting and Sequencing Antibody-Drug Conjugates in Advanced Breast Cancer

Learn More

e-Learning

Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

PRIME Education, LLC

19-Aug-2025 to 20-Aug-2026

Webinar #5 (1.5-hours) Unlocking the Power of Novel Therapies in HER2+ Breast Cancer Treatment

Learn More

e-Learning

Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations

PRIME Education, LLC

11-Sep-2025 to 12-Sep-2026

Webinar #6 (1.0-hour) Addressing Disparities in Breast Cancer: Special Considerations for Marginalized Populations – featuring real-world patient perspectives and a Clinician Spotlight

Learn More

e-Learning

Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies Into Practice

PRIME Education, LLC

30-Sep-2025 to 01-Oct-2026

Webinar #7 (1.0-hour) Breast Cancer Case Competition: Test Your Knowledge on Integrating Novel Therapies into Practice  – featuring real-world patient perspectives and a Clinician Spotlight

Learn More

e-Learning

The Future of NSCLC Care: Leveraging Biomarker Testing in the Management of Early-Stage, Resectable Disease

PRIME Education, LLC

17-Jul-2024 to 16-Jul-2025

One (1) 1.0-hour Multi-Accredited Enduring Webcast

Learn More

e-Learning

Multimodal Treatment in Early-Stage NSCLC: A Clinical Connections Session

PRIME Education, LLC

24-Jun-2025 to 24-Jun-2025

Lung Cancer Hot Topics Webinar #5

Learn More

e-Learning

Web enduring Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection

PRIME Education, LLC

01-Apr-2025 to 31-Mar-2026

Webcast #1 (1.0-hour): Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection (features 'Clinician Spotlight' from PRIME QI project)

Learn More

e-Learning

Web enduring From Guidelines to Practice: Exploring Immunotherapy in Limited-Stage Small Cell Lung Cancer

PRIME Education, LLC

30-Dec-2024 to 30-Jan-2026

0.25-hour Multi-Accredited Booster Quiz

Learn More

e-Learning

Web Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

PRIME Education, LLC

28-Jun-2024 to 03-Oct-2025

0.25-Hour Booster Quiz

Learn More

e-Learning

Web enduring Management of Brain Metastases in Patients With HER2+ Advanced Breast Cancer

PRIME Education, LLC

30-Dec-2024 to 29-Dec-2025

Clinical Case Challenge 1 (0.25-hour)

Learn More

e-Learning

Web enduring Advancing Risk-Based, Personalized Care for Veterans With mCRPC

PRIME Education, LLC

19-Nov-2024 to 18-Nov-2025

1.0-hour Multi-Accredited On-Demand Video

Learn More

e-Learning

Exploring the Evolving Role of HER2 for the Treatment of Gynecologic Cancers

PRIME Education, LLC

09-May-2025 to 08-May-2026

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (1 of 3)

Learn More

e-Learning

Latest Evidence for HER2-Directed Therapies in Hepatobiliary Cancers

PRIME Education, LLC

30-May-2025 to 29-May-2026

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (2 of 3)

Learn More

e-Learning

Emerging Clinical Data for Targeting HER2 in Bladder Cancer

PRIME Education, LLC

13-Jun-2025 to 12-May-2026

One (1) 0.5-hour Multi-Accredited, On-Demand Webcast 3-Part Series (3 of 3)

Learn More

e-Learning

Precision Therapeutic Strategies in Gynecologic Oncology: Updates & Considerations for Managed Care Professionals

Pro CE LLC.

19-Apr-2024 to 30-May-2025

On-demand, ACPE-certified enduring webcast of the live webinar, delivered through the ProCE education website; Downloadable and online-accessible teaching slideset

Learn More

e-Learning

Web enduring Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer

Efficient LLC

23-Jun-2025 to 23-Jun-2026

9-part microlearning series (4-7 minutes each; 75 mins total). Each episode to highlight critical, recent therapeutic advances across indications and disease subtypes in SCLC and NSCLC

Learn More

e-Learning

Web enduring Improving HR+/HER2- Breast Cancer Outcomes with TROP2 Antibody-Drug Conjugates

USH Axis Holdings Inc.

18-Apr-2025 to 18-Apr-2026

online enduring Chairman's Perspective

Learn More

e-Learning

Web enduring Redefining Treatment Across the Spectrum of HR+ HER2-Expressing Metastatic Breast Cancer

USH Axis Holdings Inc.

26-Sep-2025 to 26-Sep-2026

enduring program from grand rounds series

Learn More

e-Learning

Web enduring HER2-Expressing MBC In Depth: The Latest Advances in Targeted Therapies and Brain Metastases Management

Global Learning Collaborative, Inc.

06-Feb-2025 to 06-Feb-2026

MinuteCE

Learn More

e-Learning

Evolving Treatment Paradigms in Hepatocellular Carcinoma: Applying the Latest Evidence in Rural and Underserved Communities

Talem Health, LLC

30-Jun-2024 to 30-Jun-2025

An online, on-demand enduring CME/CE activity developed from the video recording of the live session - hosted on freecme.com and ruralhealthcme.com

Learn More

e-Learning

Web TROP2-Targeted Antibody-Drug Conjugates in NSCLC: An Update for Oncologists who Serve Patients in Rural and Underserved Communities

Talem Health, LLC

30-Jun-2024 to 30-Jun-2025

An online, on-demand enduring CME/CE activity developed from the video recording of the live session - hosted on freecme.com and ruralhealthcme.com

Learn More

e-Learning

Web PARP Inhibitors in Prostate Cancer: Practical Application of Recent Advances to Ensure Equitable Care in Rural and Underserved Populations

Talem Health, LLC

30-Jun-2024 to 30-Jun-2025

An online, on-demand enduring CME/CE activity developed from the video recording of the live session - hosted on freecme.com and ruralhealthcme.com

Learn More

e-Learning

Gastric and Gastroesophageal Cancer: Navigating the Evolving Treatment Landscape to Optimize Care and Advance Health Equity

Talem Health, LLC

30-Jun-2024 to 30-Jun-2025

An online, on-demand enduring CME/CE activity developed from the video recording of the live session - hosted on freecme.com and ruralhealthcme.com

Learn More

e-Learning

Web enduring Improving Equity in Endometrial Cancer Care and Treatment: Accelerating Change to Improve Patient Outcomes in Rural and Underserved Communities

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More

e-Learning

Web enduring Evolving Treatment Paradigms in HR+/HER2- Early Breast Cancer: Advancing Equitable Care in Rural and Underserved Communities

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

 An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More

e-Learning

Web enduring Targeting the PI3K/AKT/PTEN Pathway for Treatment of Breast Cancer: Innovative Solutions for Equitable Care

Talem Health, LLC

15-Dec-2024 to 15-Dec-2025

An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally

Learn More

e-Learning

Update on Surveillance and Management of HCC for Primary Care Clinicians: A Guide for Improving Outcomes in Rural and Underserved Communities

Talem Health, LLC

28-Feb-2025 to 28-Feb-2026

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More

e-Learning

Web Enduring Official Best of San Antonio Breast Cancer Symposium 2024 Video Highlights

Encore Medical Education, LLC

11-Dec-2024 to 01-Dec-2025

This educational program includes original presentation slides accompanied by commentary from key opinion leaders (KOLs) in a micro-learning video format available for viewing within 12hours of the original presentation

Learn More

e-Learning

Expert Perspectives: The Role of Immunotherapy in Advancing the Treatment of HCC and BTC

The France Foundation

24-Sep-2024 to 03-Sep-2025

Tumor-board case based online learning activity

Learn More

e-Learning

AC24 Bundle: 31 ACPE, including 8 BCOP

Hematology/Oncology Pharmacy Association

21-May-2024 to 21-May-2025

Welcome to the Annual Conference 2024 On-Demand Conference Sessions!

The sessions in this bundle were presented live in Tampa, FL on April 3-6, 2024.

Learn More

e-Learning

Addressing HER2 Alterations in Advanced NSCLC With Antibody-Drug Conjugate Therapy: Updates for The Community Oncologist

Med Learning Group, LLC

21-Nov-2024 to 21-Nov-2025

1-hr enduring activity of the live TeleECHOs of the same grant

Learn More

e-Learning

Are You Up to Date in the Management of HER2-Positive Solid Tumors? Focusing on Gastric and GEJ Cancer From Evaluation to Clinical Efficacy and Adverse Event Monitoring

Med Learning Group, LLC

12-Dec-2024 to 12-Dec-2025

Interactive enduring Grand Rounds program focusing on advanced HER2-expressing GC or GEJ cancers providing critical review of clinical trial findings and practical guidance on multidisciplinary monitoring.

Learn More

e-Learning

Are You Up to Date on the Latest Data on HER2-Targeted Antibody-Drug Conjugates for HER2-Expressing Solid Tumors?

Med Learning Group, LLC

02-Jan-2025 to 02-Jan-2026

A 1 Hour endured presentation of the Live Grand Rounds associated with this grant. 

Learn More

e-Learning

Chronic Lymphocytic Leukemia: An Evolving Treatment Landscape

Med Learning Group, LLC

06-Dec-2024 to 06-Dec-2025

1-hr enduring activity of TeleECHO session from this grant

Learn More

e-Learning

Gastric and Gastroesophageal Junction Cancers: What’s Her2 Got to Do With It?

Med Learning Group, LLC

19-Jun-2024 to 19-Jun-2025

Smart Reach Replay Enduring

Learn More

e-Learning

web enduring Optimizing HER2 Testing for Advanced Breast Cancer: Guiding Treatment with HER2-Targeted Antibody-Drug Conjugates

Med Learning Group, LLC

20-Dec-2024 to 20-Dec-2025

Enduring focused on HER2-directed ADCs for HER2+/HER2-low advanced/metastatic BC, practical guidance to incorporate testing & best practices, clinical guidelines, trial findings, and monitoring & management of key treatment-related adverse events

Learn More

e-Learning

Live Online Enduring Program

Med Learning Group, LLC

29-Nov-2024 to 29-Nov-2025

Online Enduring Program of recorded Grand Round available for 1 year. 

Learn More

e-Learning

Web enduring Recognizing the Role of TROP2 in NSCLC Management: Biologic Rationale, Clinical Data, and Community Oncologists as Champions of Multidisciplinary Care

Med Learning Group, LLC

29-Nov-2024 to 29-Nov-2025

1-hr enduring activity of live Grand Rounds under this grant

Learn More

e-Learning

Web enduring Smart Reach Replay Enduring

Med Learning Group, LLC

30-Oct-2024 to 30-Oct-2025

This interactive program combines didactic instruction with case-based discussions and illustrative animations.

Learn More

e-Learning

Session 2: Transforming CLL Management – Leveraging Emerging Data

Partners for Advancing Clinical Education

28-Jan-2025 to 28-Jul-2025

Get up to speed with key findings from the 2024 ASH® Annual Meeting. These two expert-led sessions provide critical updates on MCL and CLL

Learn More

e-Learning

Session 1: Advancing MCL Care – From Clinical Insights to Practical Applications

Partners for Advancing Clinical Education

07-Feb-2025 to 07-Aug-2025

Get up to speed with key findings from the 2024 ASH® Annual Meeting. These two expert-led sessions provide critical updates on MCL and CLL

Learn More

e-Learning

Optimal Use of BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia in the Veteran Population

Plexus Communications LLC

29-May-2024 to 29-May-2025

This educational activity is divided into 4 microlearning activities that are focused on educating oncology care teams about BTK inhibitors in CLL treatment

Learn More

e-Learning

Immunotherapy for Small-Cell Lung Cancer: Addressing Treatment Challenges

Plexus Communications LLC

15-Nov-2024 to 15-Nov-2025

This educational program aims to equip the healthcare team with the latest advancements and key insights into the treatment of small-cell lung cancer (SCLC).

Learn More

e-Learning

Web enduring Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

Plexus Communications LLC

24-Jan-2025 to 24-Jan-2026

This activity focuses on the latest developments in antibody-drug conjugates (ADCs) for NSCLC and their expanding role in patient care. 

Learn More

e-Learning

Novel Strategies in Mantle Cell Lymphoma: A Focus on BTK Inhibitors in the Front Line

Plexus Communications LLC

14-Nov-2024 to 14-Nov-2025

This program aims to equip healthcare teams with the latest insights on mantle cell lymphoma. Participants will gain essential tools to evaluate the efficacy, safety, and clinical application of new and emerging BTK inhibitors (BTKi).

Learn More

e-Learning

Expanding Targets in NSCLC: Updates on HER2- and TROP-2-directed Therapies

Haymarket Medical Education

31-Mar-2025 to 31-Mar-2026

•60-minute (1.0 credit hour) infographic webcast

Learn More

e-Learning

Web enduring PARP Inhibitors for Metastatic Prostate Cancer in the VHA Health System: Integrating New Agents into Practice

Plexus Communications LLC

14-Feb-2025 to 14-Feb-2026

This program equips clinicians with the knowledge to optimize care for patients with metastatic prostate cancer (mPC) by integrating PARP inhibitors into practice. 

Learn More

e-Learning

Optimizing Personalized Care of Patients with CLL or MCL Using BTK Inhibitors in the Frontline and Relapsed/Refractory Settings

Plexus Communications LLC

06-Jan-2025 to 06-Jan-2026

This course helps clinicians optimize CLL/MCL treatment with BTKi agents in frontline and R/R settings, focusing on personalized therapy planning, veteran-specific predispositions, comorbidities, and resistance patterns.

Learn More

e-Learning

Web enduring Targeting EGFR Alterations at Exons 19 and 21 in Veterans with Non-Small Cell Lung Cancer: Bringing Therapeutic Advances into the Clinic

Plexus Communications LLC

28-Feb-2025 to 08-Feb-2026

This program equips clinicians with the knowledge to optimize care for patients with NSCLC and EGFR exon 19 and 21 alterations. Participants will learn about current molecular testing strategies and how these inform treatment decisions.

Learn More

e-Learning

Web Hybrid Community/VHA Oncology Forums: EGFR Exons 19 and 21 Alterations in Non-Small Cell Lung Cancer: Recent Therapeutic Advances and Implications for Care

Plexus Communications LLC

22-Jan-2025 to 22-Jan-2026

This program offers comprehensive education for oncology and lung cancer MDC teams on managing NSCLC with EGFR exon 19 and 21 alterations.

Learn More

e-Learning

Web enduring The Final Frontier: Emerging Strategies in HER2-Positive Breast Cancer Brain Metastases

Efficient LLC

30-Dec-2024 to 30-Jun-2025

For this program, 32 renowned BC specialists from the US and the European Union completed a questionnaire documenting their perspectives on several of the field’s most deeply debated and evolving issues. 

Learn More

e-Learning

SIO 2025 Annual Meeting

Society of Interventional Oncology

01-April-2025 to 03-Feb-2026

SIO 2025 will offer an innovative education program including didactic sessions, panel discussions, tumor boards, case-based reviews and lectures to meet the needs of attendees.  

Learn More

e-Learning

Tweetorial Series

American Society for Clinical Pathology

22-Aug-2024 to 30-Aug-2025

Tweetorials (10 -15 threaded tweets) will reinforce concepts in pan-tumor HER2 testing and potential clinical implications around treatment planning.

Learn More

e-Learning

Web Updated Germline Testing Guidelines

Integrity CE LLC

15-Apr-2025 to 14-Apr-2026

Bi-directional social media activity that applies a thought-provoking call to action accompanied by a succinct summary image and a video of faculty discussing topic

Learn More

e-Learning

Web TumorBoard Tues (TBT) – A Twitter-based Tumor Board Bi-directional Case Discussion Series -  Cases in Breast Cancer

Integrity Continuing Education, Inc.

16-Apr-2024 to 27-May-2025

Twitter-based clinical case presentation series that replicates the format of the live in-practice tumor board presentations. Discussions are bi-directional and focus on evidence based treatment

Learn More

e-Learning

CME/NCPD-approved Virtual Tumor Board

i3 Health LLC

26-Jun-2025 to 25-Jun-2025

This activity will provide a collaborative platform for expert oncology, pathology, and nursing faculty to discuss comprehensive management strategies for prostate cancer, aiming to improve clinician competence and patient outcomes.

Learn More

e-Learning

live web Integrating PARP Inhibitors for the Treatment of Metastatic Prostate Cancer: Optimizing Personalized Care in the VHA and Community Health Care Systems

Plexus Communications LLC

24-Mar-2025 to 30-Sep-2025

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More

e-Learning

Hybrid VHA Oncology Clinical Forums: Optimizing Mantle Cell Lymphoma Management in the VHA: Innovative Strategies with BTK Inhibitors in Front-Line Therapy

Plexus Communications LLC

24-Mar-2025 to 28-Nov-2025

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More

e-Learning

Hybrid VHA Oncology Clinical Forums: Optimizing Second- and Next-Generation BTK Inhibitor Use in the Management of Chronic Lymphocytic Leukemia for Veterans

Plexus Communications LLC

02-May-2025 to 31-Dec-2025

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More

e-Learning

Live web Hybrid Community/VHA Oncology Forums: Improving Patient Outcomes via Antibody-Drug Conjugates in Non-Small Cell Lung Cancer

Plexus Communications LLC

05-Dec-2024 to 19-Nov-2025

1 hour live hospital-based meetings in hem/onc departments nationwide

Learn More

e-Learning

Journey Through the Breast Cancer Clinic: A Spectrum of HER2 Expression to Guide Treatment Decisions

Partners for Advancing Clinical Education

15-Sep-2024 to 15-Sep-2025

On-demand video

Learn More

e-Learning

Web Navigating Treatment Selection for Newly Diagnosed and Relapsed/Refractory BTC in the Era of Personalized Oncology Care

Partners for Advancing Clinical Education

13-Nov-2024 to 13-Nov-2025

The proposed 60-minute on-demand CME activity will be led by two GI oncology specialists.

Learn More

e-Learning

Web Establishing the Collaborative Benchmark for HCC Care Critical Discussions Between Interventional Radiologists and Oncologists to Maximize Therapeutic Benefit

PVI, PeerView Institute for Medical Education

15-May-2023 to 14-June-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care

PVI, PeerView Institute for Medical Education, Inc.

25-Apr-2024  to 24-May-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Maximizing the Role of ADCs in Urothelial Carcinoma: Practical Tips for Patient Selection, Safety Management, and Collaborative Care

PVI, PeerView Institute for Medical Education, Inc.

02-Jun-2024  to 01-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Precision Tactics in HER2-Positive GI Malignancies: Capitalizing on HER2-Targeted Regimens to Improve Outcomes for Gastric/GEJ Cancers, CRC, and BTC

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2024  to 30-Jun-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Achieving Optimal SCLC Care With Established and Innovative Therapies: Latest Evidence, Key Ongoing Trials, and Practical Considerations for Real-World Practice

PVI, PeerView Institute for Medical Education, Inc.

03-Jun-2024  to 02-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Redefining Frontlines in CLL: Key Questions on the Role of CIT, BTKi Standards, and Innovative BTKi Combinations

PVI, PeerView Institute for Medical Education, Inc.

28-May-2024 to 27-May-2025

0.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Rethinking and Refining Endometrial Cancer Care in the Modern Age of Precision Medicine: How to Translate Clinical Evidence into Meaningful Improvements for Patients

PVI, PeerView Institute for Medical Education, Inc.

02-Aug-2024  to 01-Aug-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Accelerating Therapeutic Progress in HER2-Positive and HER2-Low Breast Cancer: State of the Science and Guidance for Individualized Clinical Decisions

PVI, PeerView Institute for Medical Education, Inc.

01-Jun-2024  to 30-Jun-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Opening With Innovation in Chronic Lymphocytic Leukemia (CLL): The Practicalities and Potential of Finite Therapy With Bruton Tyrosine Kinase Inhibitor (BTKi) Platforms

PVI, PeerView Institute for Medical Education, Inc.

18-Jun-2024  to 17-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Mastering Multidirectional Tactics in HCC: Expert Guidance on Emerging Trends With Systemic Therapy Options Across the Disease Continuum

PVI, PeerView Institute for Medical Education, Inc.

03-Jun-2024  to 02-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide for 2024

PVI, PeerView Institute for Medical Education, Inc.

02-Jun-2024  to 01-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Illuminating the Path With Immunotherapy for Metastatic, Locally Advanced, and Early-Stage NSCLC

PVI, PeerView Institute for Medical Education, Inc.

02-Jun-2024  to 01-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Exceeding Expectations in CLL: Workshops on Targeted Standards, Sequential Options, and Emerging Therapeutics for Team-Based Care

Medical Learning Institute Inc

04-Sep-2024 to 03-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Rising to the Challenges of Early and Advanced HR+ Breast Cancer: Examining Complex Evidence to Inform Clinical Decisions

PVI, PeerView Institute for Medical Education, Inc.

03-Jun-2024  to 02-Jul-2024

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Personalized Care and Tailored Treatment Plans for Gynecologic Cancers Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches

PVI, PeerView Institute for Medical Education, Inc.

31-Dec-2024  to 30-Dec-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Live Web Personalized Care and Tailored Treatment Plans for Gynecologic Cancers: Practical Nurse Guidance on Utilizing Modern Therapeutic Approaches

PVI, PeerView Institute for Medical Education, Inc.

19-Jan-2025  to 30-Dec-2025

In this activity, developed with NOCC and FWC, oncology nurse experts provide insights on managing gynecologic cancers, including diagnostic testing, treatment support, adverse event management, patient education, and actionable care strategies.

Learn More

e-Learning

Crafting Custom Care in CLL: Guidance on Upfront and Sequential Treatment Decisions With Targeted and Immune-Based Platforms

PVI, PeerView Institute for Medical Education, Inc.

06-Dec-2024  to 05-Jan-2026

In collaboration with the CLL Society, PeerView’s Candid Conversations & Clinical Consults event at the ASH Annual meeting provided expert-led discussions and practical case-based guidance to help learners address common clinical challenges in CLL.

Learn More

e-Learning

Elevating Expectations, Broadening Impact: How to Leverage Immunotherapy and EGFR-Targeted Therapy to Improve Outcomes in Unresectable Stage III NSCLC

PVI, PeerView Institute for Medical Education, Inc.

08-Sep-2024  to 07-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Mastering Multidirectional Tactics in HCC: Expert Guidance on Emerging Trends With Systemic Therapy Options Across the Disease Continuum

PVI, PeerView Institute for Medical Education, Inc.

03-Jun-2024  to 02-Jul-2025

1.5 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web Elevating Care in Resectable Stage I-III NSCLC: Targeted Therapy and Immunotherapy at the Forefront of Multimodal Treatment Strategies

PVI, PeerView Institute for Medical Education, Inc.

09-Sep-2024 to 08-Oct-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web The Innovation Intersection in B-Cell Cancers: Navigating Choices With Modern Targeted Strategies, Cellular Therapy, and HCT

PVI, PeerView Institute for Medical Education, Inc.

13-Feb-2025 to 12-Mar-2026

On-demand activity, based on a 2025 Tandem Meetings symposium, explores advances in CLL and MCL. Experts discuss how targeted and immunotherapies have reshaped B-cell cancer management and impacted HCT use.

Learn More

e-Learning

Optimizing PARP Inhibitor Therapy in Veterans With Prostate Cancer: A Practical Guide for VA Pharmacists

PVI, PeerView Institute for Medical Education, Inc.

11-Nov-2024 to 10-Dec-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web endurig Integrating Immunotherapy in Resectable NSCLC: How to Modify Treatment Trajectories and Reorganize Multidisciplinary Care Pathways

PVI, PeerView Institute for Medical Education, Inc.

10-Oct-2024 to 09-Nov-2025

0.75 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Off-the-Shelf and On the Mark in NHL: Strategic Approaches With Bispecific Antibodies and ADCs for Enhanced DLBCL and FL Care

PVI, PeerView Institute for Medical Education, Inc.

31-Jul-2025 to 30-Jul-2026

In this on-demand enduring activity, faculty will explore real-world strategies for selecting, sequencing, and safely delivering modern and emerging off-the-shelf immunotherapies through engaging MasterClass lectures and practical case discussions.

Learn More

e-Learning

Web Enduring Reinforcing Precision Tactics in Genomically Altered Resectable NSCLC: Collaborative Workflows and Personalized Solutions for Integration of Adjuvant EGFR- and ALK-Targeted Therapies

PVI, PeerView Institute for Medical Education, Inc.

10-Oct-2024 to 09-Nov-2025

0.75 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

Web A Recap of Therapeutic Advances in HER2-Positive, HER2-Low, and HER2-Ultralow Breast Cancer: Navigating the Latest Evidence and Maximizing Clinical Impact

PVI, PeerView Institute for Medical Education, Inc.

28-Jan-2025 to 27-Jan-2026

PeerView on-demand activity delivering evidence on ADCs and novel therapies for HER2-positive, HER2-low, or HER2-ultralow breast cancer and guiding their integration into personalized treatment plans.

Learn More

e-Learning

Maximizing Therapeutic Innovations in Bladder Cancer: Expert Strategies for Comprehensive Care Across Disease Stages

PVI, PeerView Institute for Medical Education, Inc.

15-Feb-2025 to 14-Mar-2026

Join this CME/MOC/AAPA/IPCE-certified activity, held with BCAN alongside the 2025 ASCO® GU Cancers Symposium. Gain expert insights on selecting treatments, personalizing care, and integrating modern immunotherapy and targeted therapies.

Learn More

e-Learning

Fortifying the Framework for HER2+ GI Cancers: Precision Treatment Planning With Molecularly Targeted Therapies in GC/GEJC, CRC, and BTC

PVI, PeerView Institute for Medical Education

24-Jan-2025 to 24-Jan-2025

This MasterClass & Practicum at ASCO GI 2025 offers GI care teams concise lectures with comprehensive guidance on evidence-based integration and practical use of validated targeted therapies for HER2+ GI malignancies.

Learn More

e-Learning

Web enduring “Experts vs AI” ADC Challenge—Lung Cancer Edition: Interpreting the Evidence, Exploring Practicalities

PVI, PeerView Institute for Medical Education

21-Feb-2025 to 20-Mar-2026

n this interactive session, based on a live event and featuring ongoing audience engagement, the faculty panel present challenging questions and case scenarios to AI, then analyze and discuss the accuracy of its responses.

Learn More

e-Learning

Web enduring A New Era in Treating Advanced Ovarian Cancer: Practical Tips for Maximizing the Use of PARP Inhibitors, Immunotherapy, and ADCs

PVI, PeerView Institute for Medical Education

15-Mar-2025 to 14-Apr-2026

This activity, recorded at SGO 2025 in collaboration with the Foundation for Women’s Cancer, offers expert insights on optimizing PARP inhibitors, immunotherapy, ADCs, and emerging targeted regimens.

Learn More

e-Learning

Precision Medicine Crafts a New Story for Metastatic Prostate Cancer: The Next Act of Therapeutic Intensification With AKT Inhibition and Beyond

PVI, PeerView Institute for Medical Education

14-Feb-2025 to 13-Mar-2026

This on-demand activity, based on a live ASCO GU 2025 symposium, explores AKT inhibition’s role in targeting the PI3K/AKT/PTEN pathway and advancing personalized care in advanced prostate cancer.

Learn More

e-Learning

Accelerating Innovation in Biliary Tract Cancer: Restructuring Treatment Models With Immunotherapy & Targeted Platforms in Advanced Disease

PVI, PeerView Institute for Medical Education

23-Jan-2025 to 23-Jan-2025

In collaboration with the Cholangiocarcinoma Foundation, this live event at the 2025 ASCO GI Cancers Symposium will offer expert guidance on treatment decisions, therapy selection, and personalized care with immunotherapy and targeted platforms.

Learn More

e-Learning

Putting Precision Into Practice for Bladder Cancer Treatment: Insights for Individualized Care Across the Disease Continuum

PVI, PeerView Institute for Medical Education

28-Apr-2025 to 27-May-2025

In this activity, expert faculty provide guidance on bringing scientific advances to patients with bladder cancer as they review the latest clinical data, guideline recommendations, and real-world applications of modern bladder cancer therapies. 

Learn More

e-Learning

Refining the First Strike Against EGFR-Mutated Advanced NSCLC

PVI, PeerView Institute for Medical Education, Inc.

22-Nov-2024 to 21-Dec-2025

1.0 credit hour learner-interactive online enduring activity & point-of-care practice tools

Learn More

e-Learning

From Innovation to Implementation: Unlocking the Full Potential of Antibody-Drug Conjugates in Solid Tumors

PVI, PeerView Institute for Medical Education

28-Apr-2025 to 27-May-2025

This activity covers the latest trial data on diverse ADC modalities in breast, lung, GI, GU, and other cancers.

Learn More

e-Learning

Web Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PVI, PeerView Institute for Medical Education, Inc.

27-Jan-2025 to 26-Jan-2026

PeerView on-demand activity providing the latest evidence and guidelines on consolidation immunotherapy in LS-SCLC.

Learn More

e-Learning

Web enduring Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice

PVI, PeerView Institute for Medical Education, Inc.

26-Jan-2025 to 25-Feb-2026

In this on-demand activity from the 2025 STS Annual Meeting, experts share insights on stage I-III rNSCLC via tumor board-style cases, guiding learners in identifying immunotherapy candidates, selecting optimal approaches, and supporting patients.

Learn More

e-Learning

Web Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR & ALK TKI Therapy

PVI, PeerView Institute for Medical Education, Inc.

25-Jan-2025 to 24-Jan-2026

In this PeerView activity from the 2025 STS Annual Meeting, NSCLC experts discuss the latest evidence and guidelines on EGFR- & ALK-targeted therapies as adjuvant and neoadjuvant treatments for EGFR- & ALK-mutated NSCLC.

Learn More

e-Learning

Web Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity

PVI, PeerView Institute for Medical Education, Inc.

14-May-2025 to 13-Jun-2026

Experts explore neoadjuvant, adjuvant, and perioperative immunotherapy advances and address key questions in this enduring activity based on a live thoracic oncology event.

Learn More

e-Learning

Web Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC

PVI, PeerView Institute for Medical Education, Inc.

15-May-2025 to 14-Jun-2026

In this activity, based on a live event, experts share key evidence and case guidance on biomarker testing and targeted therapies for resectable NSCLC.

Learn More

e-Learning

Getting On the Right Tract: Patient-Centered Strategies to Diagnose Biliary Tract Cancers

Answers in CME Inc.

25-Jun-2024  to 24-Jun-2025

In this activity, an expert in gastrointestinal oncology discusses patient-centered approaches to the diagnosis and treatment of biliary tract cancer.

Learn More

e-Learning

Web ME Highlights: The Principles of Care in Advanced NSCLC: An Advanced Practitioners' Guide to Antibody Drug Conjugates

Answers in CME Inc.

09-Dec-2024  to 08-Dec-2025

Key takeaways, session highlights, complete recordings, and downloadable slides from the JADPRO live session

Learn More

e-Learning

Web enduring ME Highlights: TROP2-Directed ADCs in the Treatment of Advanced NSCLC: Answering Key Questions to Establish Evidence-Based Practices

Answers in CME Inc.

26-Dec-2024  to 25-Dec-2025

Summarize the most salient information from the Virtual Live, in a text- and slide-based format, divided into 5 sessions.

Learn More

e-Learning

Keeping Pace With TROP2-Directed ADCs in HR-Positive, HER2-Negative/Low Advanced Breast Cancer

Answers in CME Inc.

19-Dec-2024  to 18-Dec-2025

Fast-paced, interactive, microburst sessions with expert faculty commentary.

Learn More

e-Learning

Web enduring Expanding Pathways of Care for HER2-Positive Metastatic NSCLC: Beyond Mutation to Overexpression

Answers in CME Inc.

19-Dec-2024  to 18-Dec-2025

An expert in NSCLC discusses testing for overexpression of HER2 in patients with metastatic NSCLC, as well as clinical skills related to treatment selection/management for HER2-overexpressing NSCLC

Learn More

e-Learning

Web enduring ME Highlights: Decoding HER2 Low and Ultralow in Breast Cancer: The Path to Precision Care With Antibody-Drug Conjugates

Answers in CME Inc.

06-May-2025  to 05-May-2026

Enduring initiative with content highlighting the most salient points from all 3 Virtual Live Micro Series events

Learn More

e-Learning

Live NSCLC Learning Collaborative

American Society for Clinical Pathology

17-Mar-2025  to 24-Jul-2025

A learning collaborative is a small-group approach to support practice change by enabling pathologists and laboratory professionals to come together, discuss key concepts, and identify ways to implement changes in the laboratory.

Learn More

e-Learning

Panel Discussion at the 2025 ASCP Annual Meeting

American Society for Clinical Pathology

17-Nov-2025  to 20-Nov-2025

60-minute live panel discussion at ASCP’s November 2025 Annual Meeting in Atlanta. During this session, a moderated panel will discuss how their organizations have been developing ways to optimize biomarker testing processes in NSCLC. 

Learn More

e-Learning

Downloadable Resource Guide

American Society for Clinical Pathology

24-Oct-2025 to 11-Jan-2027

A non-accredited Resource Guide to empower pathologists and laboratory professionals on ways to operationalize testing pathways that will lead to timely, effective, efficient, and equitable testing for patients diagnosed at their institutions.

Learn More

e-Learning

On-Demand Recording of the ASCP Panel Discussion

American Society for Clinical Pathology

09-Jan-2026 to 11-Jan-2027

To further extend the reach of the Annual Meeting session, ASCP will develop one CME/CMLE-accredited on-demand recording from the Annual Meeting Session.

Learn More

e-Learning

Case-Based Microlearning Series

American Society for Clinical Pathology

03-Feb-2025 to 11-Jan-2027

An interactive, online CME/CMLE credit-bearing microlearning series consisting of 1 hour of case-based education on biomarker testing and treatment for NSCLC segmented into 4 easily consumable 15-minute segments.

Learn More

e-Learning

Inside the Lab Podcast

American Society for Clinical Pathology

09-Jan-2026 to 11-Jan-2027

45-minute CME/CMLE-accredited podcast, titled “Advances in NSCLC Biomarker Testing.” 

Learn More

e-Learning

Resource Guide

American Society for Clinical Pathology

28-Feb-2025 to 30-Aug-2025

ASCP will develop a non-accredited Resource Guide to guide members of the pathology team on ways to prepare the laboratory and operationalize processes around HER2 testing for various types of solid tumors.

Learn More

e-Learning

Activity 2: HER2-Low and HER2-Ultralow Playbook

American Society for Clinical Pathology

19-May-2025 to 30-Dec-2025

A PDF playbook that pathologists and laboratory professionals may use to assess their current practices and make changes to improve how they perform HER2 testing and how they report and communicate HER2-low and HER2-ultralow results.   

Learn More

e-Learning

Activity 3: Pathology Pointer Infographic

American Society for Clinical Pathology

26-May-2025 to 30-Dec-2025

The key highlights and practical takeaways from the HER2-Low and HER2-Ultralow Playbook will be highlighted as a “Pathology Pointer” infographic.

Learn More

e-Learning

Activity 4: Micro Video Bites

American Society for Clinical Pathology

23-Jun-2025 to 30-Dec-2025

A series of four“micro video bites”  designed using a form of whiteboard video animation. Each video will be 2-3 minutes long and will address a specific aspect of HER2 testing and interpretation.

Learn More

e-Learning

AWeb enduring ctivity 1: Microlearning Series

American Society for Clinical Pathology

17-Mar-2025 to 30-Dec-2025

Three (3) case-based microlearning activities. Each activity will include a patient case, and learners will answer questions designed to help them carefully consider the nuances of HER2-low and HER2-ultralow breast cancer diagnosis.

Learn More

e-Learning

Microlearning Series

American Society for Clinical Pathology

14-Oct-2024 to 30-Aug-2025

A series of three brief online, on-demand CME/CMLE credit-bearing courses will be developed to increase understanding of HER2 testing in different solid tumors

Learn More

e-Learning

Enduring recording of Annual Meeting Session

American Society for Clinical Pathology

09-Dec-2024 to 30-Aug-2025

To further extend the reach of the ASCP Annual Meeting session on Pan Tumor Her2 testing, ASCP will develop an CME/CMLE-accredited enduring recording.

Learn More

e-Learning

Web enduring Question of the Week

American Society of Breast Surgeons

01-Jan-2025 to 31-Dec-2025

Question of the Week Program (QOTW) is a weekly, web-based test allowing members to learn more about topics where there are gaps in education.  

Learn More

e-Learning

Navigating New Waters for Advanced or Recurrent Endometrial Cancer

Creative Educational Concepts, LLC 

23-Jul-2024 to 23-Jul-2025

Expert faculty guide learners through integration of appropriate, guideline-directed molecular profiling strategies in the EC risk assessment and treatment decision process, and assess the latest efficacy and safety data for the treatment of EC.

Learn More

e-Learning

NCCN 2024 Annual Congress: Hematologic Malignancies™

National Comprehensive Cancer Network, Inc.

01-Dec-2024 to 30-Nov-2025

Recorded presentation from the live sessions.

Learn More

e-Learning

Web enduring The GOG Highlight Reel, An Education Series

The GOG Foundation, Inc.

10-Feb-2025 to 24-Jul-2025

An Education Series Highlighting Newsworthy Data Distillation and Emerging Global Therapies in Clinical Trials

Learn More

e-Learning

Web Selected Session On-demand

Integrity Continuing Education, Inc.

31-Jul-2024 to 30-Jul-2025

This 2-day, case-based symposium will offer practical guidance for best practices across malignancies.

Learn More

e-Learning

HCC Think Tank Activity

Integrity Continuing Education, Inc.

14-Aug-2024 to 13-Aug-2025

HCC Think Tank Activity-Faculty discussion will focus on the new and emerging agents for the treatment of hepatocellular carcinoma that have potential to change the standard of care. 

Learn More

e-Learning

Web On the Horizon: Expert Insights Into New and Emerging Novel ADCs for the Treatment of Advanced Solid Tumors

Paradigm Medical Communications, LLC

31-May-2024 to 31-May-2025

In this enduring program, the content presented at the live symposium is converted into a more concise 1.0-hour, CME-certified, interactive video webinar highlighting key discussions and takeaways from the live event

Learn More

e-Learning

Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations

PeerVoice America Limited

19-Dec-2023 to 18-Dec-2025

Two 10-minute expert-led panel discussion presentations

Learn More

e-Learning

TROP2-Directed Antibody-Drug Conjugates for Breast Cancer: The Clinical Significance of the Construct

PeerVoice America Limited

25-Jan-2024 to 24-Jan-2026

20 minute web enduring activity with experts discussing TROP2-directed antibody-drug conjugates (ADCs) for breast cancer.

Learn More

e-Learning

Testing Impacts Treatment: Applying Best Practices in HER2 Assessment in Solid Tumours

PeerVoice America Limited

08-Nov-2024 to 07-Nov-2026

An expert discusses HER2 assessment and therapeutic management in solid tumours.

Learn More

e-Learning

Web enduring Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting

PeerVoice America Limited

30-Sep-2024 to 29-Sep-2026

In this video CE activity, Karin Jordan, MD, PhD, explores strategies for preventing and managing antibody-drug conjugate-associated nausea and vomiting

Learn More

e-Learning

Pathological Assessment of HER2 Status in Gastric and Gastroesophageal Cancers: Important Steps That Can Impact Outcomes

PeerVoice America Limited

27-Sep-2024 to 26-Sep-2026

5 Micro Episodes (5 min each) with an Experts presentation

Learn More

e-Learning

Web When They Need More Than Trastuzumab: Deciding on What’s Next for Patients With HER2+ Gastric Cancer

PeerVoice America Limited

11-Sep-2024 to 10-Sep-2026

5 Micro Episodes (5 mins each) with an expert's presentation

Learn More

e-Learning

Applying Foresight to Optimise Emesis Control in Patients Receiving Antibody-Drug Conjugates

PeerVoice America Limited

31-Oct-2024 to 30-Oct-2026

In this two-part video CE activity, Karin Jordan, MD, PhD, and Erika Hamilton, MD, discuss strategies for controlling emesis in patients who are receiving antibody-drug conjugates.

Learn More

e-Learning

When HER2 Is Low or Negative: Emerging Evidence on Antibody-Drug Conjugates for Hormone Receptor-Positive and Triple-Negative Breast Cancers

PeerVoice America Limited

30-Nov-2024 to 29-NOv-2025

20 minute web enduring activity with experts in oncology discussing recently presented data on antibody-drug conjugates for hormone receptor-positive and triple-negative breast cancer.

Learn More

e-Learning

Case-By-Case: Optimizing Dual Checkpoint Inhibitor Combination Therapies in Advanced Driver-Negative Non-Small Cell Lung Cancer

TotalCME

15-Jul-2024 to 15-Jul-2025

1.50-hour Triple Certified (ACCME, ACPE, ANCC) MinuteCE microlearning program  

Learn More

e-Learning

Advances in HER2-Mutant NSCLC: Optimizing Outcomes in Rural and Underserved Communities

Talem Health, LLC

30-June-2024 to 30-June-2025

Online enduring activity: An online, on-demand enduring CME/CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com and marketed to the target audience nationally. (1.0 AMA/ANCC credit)

Learn More

e-Learning

Web enduring Advanced NSCLC: Empowering Nurses to Improve Patient Care in Rural and Underserved Communities

Talem Health, LLC

02-Jun-2025 to 02-Jun-2026

An online, on-demand enduring CE activity developed from the video recording of the live session will be hosted on freecme.com and ruralhealthcme.com; marketed to the target audience nationally.

Learn More

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice